IRIS

CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 112 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Ciardiello, Fortunato; Tortora, Giampaolo; Vecchio, Giancarlo; Ryan, A. J.; Fontanini, G.; Fusco, Alfredo; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 1.1 Articolo in rivista 2003 Ciardiello, F; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Vitagliano, D; Carlomagno, F; Veneziani, BIANCA MARIA; Fontanini, G; Bianco, Ar; Tortora, Giampaolo
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. 1.1 Articolo in rivista 2003 Andreozzi, F; Melillo, ROSA MARINA; Carlomagno, F; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, M; Formisano, P.
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
Ret-mediated mitogenesis requires Src kinase activity 1.1 Articolo in rivista 1999 Melillo, ROSA MARINA; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; DI FIORE, Pp; Vecchio, G; Fusco, Alfredo; Santoro, M.
Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage 1.1 Articolo in rivista 2007 M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca
Receptor tyrosine kinase inhibitors in thyroid cancer. 1.1 Articolo in rivista 2008 Castellone, Md; Carlomagno, Francesca; Salvatore, G; Santoro, Massimo
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi. 2.1 Contributo in volume (Capitolo o Saggio) 2007 Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo
Activation of RET as a dominant transforming gene by germline mutatios of MEN2A and MEN2B 1.1 Articolo in rivista 1995 Santoro, Massimo; Carlomagno, Francesca; A., Romano; D. D., Bottaro; N. A., Dathan; M., Grieco; Fusco, Alfredo; Vecchio, Giancarlo; B., Matoskova; M. H., Kraus; P. P., Di Fiore
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 4.2 Abstract in Atti di convegno 2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
Central role of RET in thyroid cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
POINT MUTATION OF THE RET PROTO-ONCOGENE IN THE TT HUMAN MEDULLARY THYROID CARCINOMA CELL LINE 1.1 Articolo in rivista 1995 Carlomagno, F.; Salvatore, Domenico; Santoro, M.; DE FRANCISCIS, V.; Quadro, L.; Panariello, L.; Colantuoni, V.; Fusco, Alfredo
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer 1.1 Articolo in rivista 1999 Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism 1.1 Articolo in rivista 1998 Cosma, Mp; Cardone, M; Carlomagno, Francesca; Colantuoni, V.
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1.1 Articolo in rivista 1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, ROSA MARINA; Bucci, C; DE FRANCISCIS, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) 1.1 Articolo in rivista 2003 Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo